Adherence to Hydroxyurea and Patients’ Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study
<i>Background and Objectives</i>: Hydroxyurea is a crucial treatment for sickle cell disease (SCD), but some patients’ adherence to it remains suboptimal. Understanding patients’ perspectives on SCD and HU is essential for improving adherence. This study aimed to assess hydroxyurea adher...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-01-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/60/1/124 |
| _version_ | 1827371518032609280 |
|---|---|
| author | Mohammed Ali Madkhali Faisal Abusageah Faisal Hakami Basem Zogel Khalid M. Hakami Samar Alfaifi Essam Alhazmi Shaden Zaalah Shadi Trabi Abdulaziz H. Alhazmi Mostafa Mohrag Hafiz Malhan |
| author_facet | Mohammed Ali Madkhali Faisal Abusageah Faisal Hakami Basem Zogel Khalid M. Hakami Samar Alfaifi Essam Alhazmi Shaden Zaalah Shadi Trabi Abdulaziz H. Alhazmi Mostafa Mohrag Hafiz Malhan |
| author_sort | Mohammed Ali Madkhali |
| collection | DOAJ |
| description | <i>Background and Objectives</i>: Hydroxyurea is a crucial treatment for sickle cell disease (SCD), but some patients’ adherence to it remains suboptimal. Understanding patients’ perspectives on SCD and HU is essential for improving adherence. This study aimed to assess hydroxyurea adherence and patients’ perceptions of SCD and hydroxyurea among SCD patients in the Jazan region of Saudi Arabia. <i>Materials and Methods</i>: This cross-sectional study collected data from 217 SCD patients using self-administered questionnaires from August 2022 to January 2023. The survey covered patient demographics, SCD consequences, and other clinical data. We used the Brief Illness Perception Questionnaire (B-IPQ) to measure patients’ disease perception and the 8-item Morisky Medication Adherence Scale (MMAS-8) to evaluate patients’ adherence to HU. Data were analysed using descriptive, <i>t</i>-test, and chi-square tests, and the <i>p</i>-value was set at <0.05 for significance. <i>Results</i>: More than half of the patients were male, with a mean age of 28.09 ± 8.40 years. About 57.6% of the patients were currently using HU. About 81.6% of HU users reported low adherence. The adherence was lower among individuals with infections/recurrent infections and in patients who received repeated blood transfusions. ICU admission, blood transfusion, and certain SCD complications were associated with HU use. Male patients had a higher perception of SCD consequences, concern, and understanding. ICU-admitted and recurrent hospitalized patients had a higher perception of the SCD-related consequences, symptoms, concerns, and emotional responses. <i>Conclusions</i>: HU seems a well-established and efficacious disease-modifying agent, but its underutilization for SCD patients remains challenging. To overcome the adherence challenges, healthcare providers must educate SCD patients about the role of hydroxyurea in lowering disease severity and addressing side effects to obtain maximum benefits. Healthcare providers may consider tailored educational interventions to improve adherence, particularly for patients with infections, recurrent hospitalizations, or repeated blood transfusions. Further research is needed to identify strategies for improving hydroxyurea adherence and patient education among SCD patients. |
| first_indexed | 2024-03-08T10:41:33Z |
| format | Article |
| id | doaj.art-b3edfe65a1ca468996c568b46effe506 |
| institution | Directory Open Access Journal |
| issn | 1010-660X 1648-9144 |
| language | English |
| last_indexed | 2024-03-08T10:41:33Z |
| publishDate | 2024-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medicina |
| spelling | doaj.art-b3edfe65a1ca468996c568b46effe5062024-01-26T17:35:28ZengMDPI AGMedicina1010-660X1648-91442024-01-0160112410.3390/medicina60010124Adherence to Hydroxyurea and Patients’ Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional StudyMohammed Ali Madkhali0Faisal Abusageah1Faisal Hakami2Basem Zogel3Khalid M. Hakami4Samar Alfaifi5Essam Alhazmi6Shaden Zaalah7Shadi Trabi8Abdulaziz H. Alhazmi9Mostafa Mohrag10Hafiz Malhan11Department of Internal Medicine, Division of Hematology and Oncology, Faculty of Medicine, Jazan University, Jazan 45142, Saudi ArabiaFaculty of Medicine, Jazan University, Jazan 45142, Saudi ArabiaFaculty of Medicine, Jazan University, Jazan 45142, Saudi ArabiaFaculty of Medicine, Jazan University, Jazan 45142, Saudi ArabiaFaculty of Medicine, Jazan University, Jazan 45142, Saudi ArabiaFaculty of Medicine, Jazan University, Jazan 45142, Saudi ArabiaFaculty of Medicine, Jazan University, Jazan 45142, Saudi ArabiaFaculty of Medicine, Jazan University, Jazan 45142, Saudi ArabiaFaculty of Medicine, Jazan University, Jazan 45142, Saudi ArabiaFaculty of Medicine, Jazan University, Jazan 45142, Saudi ArabiaDepartment of Medicine, Faculty of Medicine, Jazan University, Jazan 45142, Saudi ArabiaDepartment of Hematology, Prince Mohammed Bin Nasser Hospital, Jazan 82943, Saudi Arabia<i>Background and Objectives</i>: Hydroxyurea is a crucial treatment for sickle cell disease (SCD), but some patients’ adherence to it remains suboptimal. Understanding patients’ perspectives on SCD and HU is essential for improving adherence. This study aimed to assess hydroxyurea adherence and patients’ perceptions of SCD and hydroxyurea among SCD patients in the Jazan region of Saudi Arabia. <i>Materials and Methods</i>: This cross-sectional study collected data from 217 SCD patients using self-administered questionnaires from August 2022 to January 2023. The survey covered patient demographics, SCD consequences, and other clinical data. We used the Brief Illness Perception Questionnaire (B-IPQ) to measure patients’ disease perception and the 8-item Morisky Medication Adherence Scale (MMAS-8) to evaluate patients’ adherence to HU. Data were analysed using descriptive, <i>t</i>-test, and chi-square tests, and the <i>p</i>-value was set at <0.05 for significance. <i>Results</i>: More than half of the patients were male, with a mean age of 28.09 ± 8.40 years. About 57.6% of the patients were currently using HU. About 81.6% of HU users reported low adherence. The adherence was lower among individuals with infections/recurrent infections and in patients who received repeated blood transfusions. ICU admission, blood transfusion, and certain SCD complications were associated with HU use. Male patients had a higher perception of SCD consequences, concern, and understanding. ICU-admitted and recurrent hospitalized patients had a higher perception of the SCD-related consequences, symptoms, concerns, and emotional responses. <i>Conclusions</i>: HU seems a well-established and efficacious disease-modifying agent, but its underutilization for SCD patients remains challenging. To overcome the adherence challenges, healthcare providers must educate SCD patients about the role of hydroxyurea in lowering disease severity and addressing side effects to obtain maximum benefits. Healthcare providers may consider tailored educational interventions to improve adherence, particularly for patients with infections, recurrent hospitalizations, or repeated blood transfusions. Further research is needed to identify strategies for improving hydroxyurea adherence and patient education among SCD patients.https://www.mdpi.com/1648-9144/60/1/124sickle cell diseaseadherenceperceptionhydroxyureaJazanSaudi Arabia |
| spellingShingle | Mohammed Ali Madkhali Faisal Abusageah Faisal Hakami Basem Zogel Khalid M. Hakami Samar Alfaifi Essam Alhazmi Shaden Zaalah Shadi Trabi Abdulaziz H. Alhazmi Mostafa Mohrag Hafiz Malhan Adherence to Hydroxyurea and Patients’ Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study Medicina sickle cell disease adherence perception hydroxyurea Jazan Saudi Arabia |
| title | Adherence to Hydroxyurea and Patients’ Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study |
| title_full | Adherence to Hydroxyurea and Patients’ Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study |
| title_fullStr | Adherence to Hydroxyurea and Patients’ Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study |
| title_full_unstemmed | Adherence to Hydroxyurea and Patients’ Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study |
| title_short | Adherence to Hydroxyurea and Patients’ Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study |
| title_sort | adherence to hydroxyurea and patients perceptions of sickle cell disease and hydroxyurea a cross sectional study |
| topic | sickle cell disease adherence perception hydroxyurea Jazan Saudi Arabia |
| url | https://www.mdpi.com/1648-9144/60/1/124 |
| work_keys_str_mv | AT mohammedalimadkhali adherencetohydroxyureaandpatientsperceptionsofsicklecelldiseaseandhydroxyureaacrosssectionalstudy AT faisalabusageah adherencetohydroxyureaandpatientsperceptionsofsicklecelldiseaseandhydroxyureaacrosssectionalstudy AT faisalhakami adherencetohydroxyureaandpatientsperceptionsofsicklecelldiseaseandhydroxyureaacrosssectionalstudy AT basemzogel adherencetohydroxyureaandpatientsperceptionsofsicklecelldiseaseandhydroxyureaacrosssectionalstudy AT khalidmhakami adherencetohydroxyureaandpatientsperceptionsofsicklecelldiseaseandhydroxyureaacrosssectionalstudy AT samaralfaifi adherencetohydroxyureaandpatientsperceptionsofsicklecelldiseaseandhydroxyureaacrosssectionalstudy AT essamalhazmi adherencetohydroxyureaandpatientsperceptionsofsicklecelldiseaseandhydroxyureaacrosssectionalstudy AT shadenzaalah adherencetohydroxyureaandpatientsperceptionsofsicklecelldiseaseandhydroxyureaacrosssectionalstudy AT shaditrabi adherencetohydroxyureaandpatientsperceptionsofsicklecelldiseaseandhydroxyureaacrosssectionalstudy AT abdulazizhalhazmi adherencetohydroxyureaandpatientsperceptionsofsicklecelldiseaseandhydroxyureaacrosssectionalstudy AT mostafamohrag adherencetohydroxyureaandpatientsperceptionsofsicklecelldiseaseandhydroxyureaacrosssectionalstudy AT hafizmalhan adherencetohydroxyureaandpatientsperceptionsofsicklecelldiseaseandhydroxyureaacrosssectionalstudy |